title: AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression.
abstract: BACKGROUND
  Excess advanced glycation end-products (AGEs) are formed during renal failure, and AGE formation also may be connected with the high glucose concentration of peritoneal dialysis (PD) fluids. To determine the effect of human peritoneal mesothelial cell (HPMC) exposure to glycated proteins, we studied the HPMC receptor of AGE expression (RAGE), and analyzed the results of AGE-RAGE interaction on adhesion molecule expression and leukocyte binding.
  
  
  METHODS
  RAGE was detected by FACS analysis, and RAGE mRNA by reverse transcription-polymerase chain reaction (RT-PCR). Vascular and intercellular cell adhesion molecule (VCAM-1 and ICAM-1) expression was measured by a known radiometric technique under basal conditions, after the addition of an AGE-specific compound, Nepsilon-carboxylmethyllysine (CML-albumin). Leukocyte adhesion on HPMC was analyzed by videomicroscopy after HPMC stimulation.
  
  
  RESULTS
  RAGE protein was detected on HPMC, and RAGE mRNA was evidenced by RT-PCR. VCAM-1 expression was stimulated by CML-albumin (P < 0.01), while ICAM-1 was unchanged. By blocking the AGE-RAGE interaction, anti-RAGE antibodies or recombinant RAGE inhibited the increase in VCAM-1 expression. CML-albumin stimulation potentiated leukocyte adhesion to HPMC (P < 0.001). This effect was prevented by the incubation of leukocytes with recombinant VCAM-1 (P < 0.001).
  
  
  CONCLUSIONS
  AGE binding to RAGE stimulated mesothelial cell activity, and resulted in the overexpression of VCAM-1, a structure for leukocyte adhesion. The AGE-RAGE interaction resulted in HPMC activation, which may promote local inflammation, and thus is implicated in the peritoneal injury found in long-term PD patients.
authors.affiliation: Laboratoire de Biologie Vasculaire et Cellulaire, Institut National de la Transfusion Sanguine, and Service de Chirurgie Digestive, CHU Lariboisière, Paris, France.
authors.forename: Eric
authors.initials: E
authors.lastname: Boulanger
authors.forename: Marie-Paule
authors.initials: MP
authors.lastname: Wautier
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Wautier
authors.forename: Bernadette
authors.initials: B
authors.lastname: Boval
authors.forename: Yves
authors.initials: Y
authors.lastname: Panis
authors.forename: Nicolas
authors.initials: N
authors.lastname: Wernert
authors.forename: Pierre-Marie
authors.initials: PM
authors.lastname: Danze
authors.forename: Philippe
authors.initials: P
authors.lastname: Dequiedt
mesh_terms: D000328:Adult; D002448:Cell Adhesion / Q000276:immunology; D002478:Cells, Cultured; D005260:Female; D005434:Flow Cytometry; D015870:Gene Expression / Q000502:physiology; D017127:Glycation End Products, Advanced / Q000378:metabolism*; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000235:genetics / Q000378:metabolism; D007674:Kidney Diseases / Q000378:metabolism / Q000628:therapy; D007962:Leukocytes / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis; D010537:Peritoneum / Q000166:cytology* / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic / Q000235:genetics / Q000378:metabolism*; D014471:Umbilical Veins / Q000166:cytology; D019010:Vascular Cell Adhesion Molecule-1 / Q000235:genetics* / Q000378:metabolism
chemical_list: D017127:Glycation End Products, Advanced; D012333:RNA, Messenger; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic; D019010:Vascular Cell Adhesion Molecule-1; D018799:Intercellular Adhesion Molecule-1